Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent …

… patents) and Lupin (only for Catalyst’s FIRDAPSE patent expiring in 2037), is ongoing. As required by law, the companies will submit the …